title: Gene transfer for congestive heart failure: update 2013.
abstract: Congestive heart failure is a major cause of morbidity and mortality with increasing social and economic costs. There have been no new high impact therapeutic agents for this devastating disease for more than a decade. However, many pivotal regulators of cardiac function have been identified using cardiac-directed transgene expression and gene deletion in preclinical studies. Some of these increase function of the failing heart. Altering the expression of these pivotal regulators using gene transfer is now either being tested in clinical gene transfer trials, or soon will be. In this review, we summarize recent progress in cardiac gene transfer for clinical congestive heart failure.
authors.affiliation: Department of Medicine, University of California San Diego, and VA San Diego Healthcare System, San Diego, Calif., USA.
authors.forename: Tong
authors.initials: T
authors.lastname: Tang
authors.forename: H Kirk
authors.initials: HK
authors.lastname: Hammond
mesh_terms: D015870:Gene Expression; D018014:Gene Transfer Techniques; D005822:Genetic Vectors / Q000235:genetics; D006333:Heart Failure / Q000235:genetics* / Q000628:therapy*; D006801:Humans; D009206:Myocardium / Q000378:metabolism / Q000473:pathology; D019076:Transgenes / Q000235:genetics